Laboratory studies have shown that OPRM1 genotype moderates the subjective effects of naltrexone in social and heavy drinkers, such that G carriers reported reduced sensitivity to the stimulating effects of alcohol.[1] Moreover, a placebo-controlled study of heavy drinkers of East Asian descent demonstrated that G carriers experienced greater sensitivity to alcohol's aversive effects as compared to A homozygotes.[2]